JOHNSON & JOHNSON

JNJ
Delayed Quote. Delayed  - 10/23 09:10:00 pm
145.24USD +0.11%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Number of employees : 132 200 people.
Sales per Business
20182019
USD
(in Million)
%USD
(in Million)
%
Pharmaceutical 40,73450% 42,19851.4%
Medical Devices 26,99433.1% 25,96331.6%
Consumer 13,85317% 13,89816.9%
Sales per region
20182019
USD
(in Million)
%USD
(in Million)
%
United States 41,88451.4% 42,09751.3%
Europe 18,75323% 18,46622.5%
Asia-Pacific, Africa 14,83118.2% 15,55518.9%
Western Hemisphere Excluding United States 6,1137.5% 5,9417.2%
Managers
Name Title
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Anne M. Mulcahy Lead Independent Director
Ronald A. Williams Independent Director
Ian Edward Lamert Davis Independent Director
A. Eugene Washington Independent Director
Mark B. McClellan Independent Director
Shareholders
Name Equities %
The Vanguard Group, Inc. 219,272,027 8.33%
SSgA Funds Management, Inc. 152,571,802 5.79%
BlackRock Fund Advisors 64,724,192 2.46%
Putnam LLC 50,777,264 1.93%
Geode Capital Management LLC 39,573,737 1.50%
State Farm Investment Management Corp. 34,574,792 1.31%
Northern Trust Investments, Inc.(Investment Management) 33,972,792 1.29%
Capital Research & Management Co. 32,520,000 1.24%
Massachusetts Financial Services Co. 29,585,917 1.12%
Wellington Management Co. LLP 28,769,995 1.09%
Company contact information
Johnson & Johnson
One Johnson & Johnson Plaza
New Brunswick, NJ 08933

Phone : +1.732.524.0400
Web : http://www.jnj.com
Sector Pharmaceuticals - NEC
1st jan.Capi. (M$)
JOHNSON & JOHNSON-0.43%382 391
ROCHE HOLDING AG-5.29%280 884
PFIZER INC.-2.55%212 162
MERCK & CO., INC.-12.23%201 909
NOVARTIS AG-16.78%185 999
NOVO NORDISK A/S15.16%164 690
ABBVIE INC.-4.74%148 846
ASTRAZENECA PLC4.42%135 994
BRISTOL-MYERS SQUIBB COMPANY-6.33%135 529
AMGEN INC.-5.77%133 046
ELI LILLY AND COMPANY8.33%129 063
SANOFI-7.45%123 347
GLAXOSMITHKLINE PLC-24.46%87 270
JIANGSU HENGRUI MEDICINE CO., LTD.20.86%69 658
CHUGAI PHARMACEUTICAL CO., LTD.27.41%67 163
ALLERGAN PLC0.97%63 659
TAKEDA PHARMACEUTICAL COMPANY LIMITED-19.21%52 214
DAIICHI SANKYO COMPANY, LIMITED11.40%49 803
BAYER AG-41.73%49 336
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED35.14%26 731
ASTELLAS PHARMA INC.-20.67%26 300
Brand Portfolio
ABBOTT MEDICAL OPTIC
ABBOTT MEDICAL OPTIC
ACUVUE
ACUVUE
ACUVUE 2
ACUVUE 2
AURIS HEALTH
AURIS HEALTH
CLEAN & CLEAR ADVANTAGE
CLEAN & CLEAR ADVANTAGE
J&J
J&J
JANSSEN
JANSSEN
JANSSEN PHARMACEUTICA
JANSSEN PHARMACEUTICA
JOHNSON & JOHNSON
JOHNSON & JOHNSON
JOHNSON'S
JOHNSON'S
JOHNSON'S BABY
JOHNSON'S BABY
LE PETIT MARSEILLAIS
LE PETIT MARSEILLAIS
LISTERINE
LISTERINE
NEUTROGENA
NEUTROGENA
NINJA
NINJA
VERB SURGICAL
VERB SURGICAL
» More brands of Johnson & Johnson